Skip to main content
HR 8508 116th Congress House Government Operations and Politics Cardiovascular and respiratory health Emergency medical services and trauma care Health technology, devices, supplies Immunology and vaccination Infectious and parasitic diseases Military procurement, research, weapons development Public contracts and procurement State and local government operations Strategic materials and reserves

COVID–19 Vaccine Distribution and Production Act

Introduced: October 2, 2020 See on congress.gov
Sign in to write a letter Sign in to watch
 Everywhere this bill has been 2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Oct 2, 2020
Referred to the House Committee on Financial Services.
Oct 2, 2020
Introduced in House
 Plain-English summary Congressional Research Service

COVID-19 Vaccine Distribution and Production Act

This bill requires the President to, within one day, exercise certain authorities under the Defense Production Act of 1950 to obtain supplies necessary to distribute and administer COVID-19 (i.e., coronavirus disease 2019) vaccines. That act confers on the President a broad set of authorities to influence domestic industry in order to provide essential materials and goods for the national defense.

The President must allocate these supplies based on requests from governors and the needs of the states as determined by the population of each state.

The bill's directive to use these authorities terminates when all requests from the states have been fulfilled. Supplies that have been produced but are unused at that time must be deposited into the Strategic National Stockpile.

What's happening now October 2, 2020

Referred to the House Committee on Financial Services.

 Committees of jurisdiction 1
 Cosponsors 2
All 2 Democratic 2